| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
American Diabetes Association 2019 Conference Podcast With the Editor-in-Chief: What Are the Outcomes from ADA This Year and What Are the Future Developments in Diabetes?
|
Ovalle, Fernando
|
|
2019
|
10 |
4 |
p. 1177-1179
|
artikel
|
| 2 |
American Diabetes Association 2019 Conference Podcast With the Editor-in-Chief: What Are the Outcomes from ADA This Year and What Are the Future Developments in Diabetes?
|
Ovalle, Fernando
|
|
|
10 |
4 |
p. 1177-1179
|
artikel
|
| 3 |
Association of OSAHS Hypoxia Indicators with Early Renal Injury and Serum Fibroblast Growth Factor 21 in Obese Type 2 Diabetic Patients
|
Yu, Weinan
|
|
2019
|
10 |
4 |
p. 1357-1368
|
artikel
|
| 4 |
Association of OSAHS Hypoxia Indicators with Early Renal Injury and Serum Fibroblast Growth Factor 21 in Obese Type 2 Diabetic Patients
|
Yu, Weinan
|
|
|
10 |
4 |
p. 1357-1368
|
artikel
|
| 5 |
BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion
|
Bajaj, Sarita
|
|
2019
|
10 |
4 |
p. 1189-1204
|
artikel
|
| 6 |
BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion
|
Bajaj, Sarita
|
|
|
10 |
4 |
p. 1189-1204
|
artikel
|
| 7 |
Cardiovascular Disease in Patients with Type 2 Diabetes and in Patients Starting Empagliflozin Treatment: Nationwide Survey
|
Eliasson, Björn
|
|
2019
|
10 |
4 |
p. 1523-1530
|
artikel
|
| 8 |
Cardiovascular Disease in Patients with Type 2 Diabetes and in Patients Starting Empagliflozin Treatment: Nationwide Survey
|
Eliasson, Björn
|
|
|
10 |
4 |
p. 1523-1530
|
artikel
|
| 9 |
Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study
|
Yoo, Jee Hee
|
|
2019
|
10 |
4 |
p. 1453-1463
|
artikel
|
| 10 |
Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study
|
Yoo, Jee Hee
|
|
|
10 |
4 |
p. 1453-1463
|
artikel
|
| 11 |
Clinical Outcomes of Transmetatarsal Amputation in Patients with Diabetic Foot Ulcers Treated without Revascularization
|
Zhang, Shanshan
|
|
2019
|
10 |
4 |
p. 1465-1472
|
artikel
|
| 12 |
Clinical Outcomes of Transmetatarsal Amputation in Patients with Diabetic Foot Ulcers Treated without Revascularization
|
Zhang, Shanshan
|
|
|
10 |
4 |
p. 1465-1472
|
artikel
|
| 13 |
Clinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports
|
Thalange, Nandu
|
|
2019
|
10 |
4 |
p. 1219-1237
|
artikel
|
| 14 |
Clinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports
|
Thalange, Nandu
|
|
|
10 |
4 |
p. 1219-1237
|
artikel
|
| 15 |
Comment on “Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report” by Hsieh et al.
|
Castello, Luigi Mario
|
|
2019
|
10 |
4 |
p. 1549-1550
|
artikel
|
| 16 |
Comment on “Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report” by Hsieh et al.
|
Castello, Luigi Mario
|
|
|
10 |
4 |
p. 1549-1550
|
artikel
|
| 17 |
Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study
|
Zang, Li
|
|
2019
|
10 |
4 |
p. 1391-1405
|
artikel
|
| 18 |
Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study
|
Zang, Li
|
|
|
10 |
4 |
p. 1391-1405
|
artikel
|
| 19 |
Correction to: Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
|
Gæde, Peter
|
|
2019
|
10 |
4 |
p. 1319-1321
|
artikel
|
| 20 |
Correction to: Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
|
Gæde, Peter
|
|
|
10 |
4 |
p. 1319-1321
|
artikel
|
| 21 |
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec
|
Kawaguchi, Yuji
|
|
2019
|
10 |
4 |
p. 1535-1541
|
artikel
|
| 22 |
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec
|
Kawaguchi, Yuji
|
|
|
10 |
4 |
p. 1535-1541
|
artikel
|
| 23 |
Effect of Intravitreal Anti-Vascular Growth Factor Agents With or Without Macular Photocoagulation on Diabetic Macular Edema: A Systematic Review and Meta-Analysis
|
Cui, Lanjun
|
|
2019
|
10 |
4 |
p. 1283-1296
|
artikel
|
| 24 |
Effect of Intravitreal Anti-Vascular Growth Factor Agents With or Without Macular Photocoagulation on Diabetic Macular Edema: A Systematic Review and Meta-Analysis
|
Cui, Lanjun
|
|
|
10 |
4 |
p. 1283-1296
|
artikel
|
| 25 |
Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump Therapy
|
Turrin, Kali B.
|
|
2019
|
10 |
4 |
p. 1337-1346
|
artikel
|
| 26 |
Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump Therapy
|
Turrin, Kali B.
|
|
|
10 |
4 |
p. 1337-1346
|
artikel
|
| 27 |
Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2)
|
Li, Yan
|
|
2019
|
10 |
4 |
p. 1435-1452
|
artikel
|
| 28 |
Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2)
|
Li, Yan
|
|
|
10 |
4 |
p. 1435-1452
|
artikel
|
| 29 |
Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report
|
Kim, Hae Jin
|
|
2019
|
10 |
4 |
p. 1271-1282
|
artikel
|
| 30 |
Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report
|
Kim, Hae Jin
|
|
|
10 |
4 |
p. 1271-1282
|
artikel
|
| 31 |
GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective
|
Rasalam, Roy
|
|
2019
|
10 |
4 |
p. 1205-1217
|
artikel
|
| 32 |
GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective
|
Rasalam, Roy
|
|
|
10 |
4 |
p. 1205-1217
|
artikel
|
| 33 |
Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes
|
Doupis, John
|
|
2019
|
10 |
4 |
p. 1407-1422
|
artikel
|
| 34 |
Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes
|
Doupis, John
|
|
|
10 |
4 |
p. 1407-1422
|
artikel
|
| 35 |
Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach
|
Gentile, Sandro
|
|
2019
|
10 |
4 |
p. 1423-1433
|
artikel
|
| 36 |
Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach
|
Gentile, Sandro
|
|
|
10 |
4 |
p. 1423-1433
|
artikel
|
| 37 |
Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM
|
Osaki, Aya
|
|
2019
|
10 |
4 |
p. 1531-1534
|
artikel
|
| 38 |
Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM
|
Osaki, Aya
|
|
|
10 |
4 |
p. 1531-1534
|
artikel
|
| 39 |
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
|
Gæde, Peter
|
|
2019
|
10 |
4 |
p. 1297-1317
|
artikel
|
| 40 |
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
|
Gæde, Peter
|
|
|
10 |
4 |
p. 1297-1317
|
artikel
|
| 41 |
Maturity Onset Diabetes of the Young is Not Necessarily Associated with Autosomal Inheritance: Case Description of a De Novo HFN1A Mutation
|
Salzano, Giuseppina
|
|
2019
|
10 |
4 |
p. 1543-1548
|
artikel
|
| 42 |
Maturity Onset Diabetes of the Young is Not Necessarily Associated with Autosomal Inheritance: Case Description of a De Novo HFN1A Mutation
|
Salzano, Giuseppina
|
|
|
10 |
4 |
p. 1543-1548
|
artikel
|
| 43 |
Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials
|
Vetter, Marion L.
|
|
2019
|
10 |
4 |
p. 1249-1270
|
artikel
|
| 44 |
Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials
|
Vetter, Marion L.
|
|
|
10 |
4 |
p. 1249-1270
|
artikel
|
| 45 |
Post-Basal Insulin Intensification and Healthcare Resource Use in Type 2 Diabetes: A Web-Based Physician Survey in the United States and United Kingdom
|
Brod, Meryl
|
|
2019
|
10 |
4 |
p. 1323-1336
|
artikel
|
| 46 |
Post-Basal Insulin Intensification and Healthcare Resource Use in Type 2 Diabetes: A Web-Based Physician Survey in the United States and United Kingdom
|
Brod, Meryl
|
|
|
10 |
4 |
p. 1323-1336
|
artikel
|
| 47 |
Prevalence of Diabetes and Prediabetes in Adults from a Third-Tier City in Eastern China: A Cross-Sectional Study
|
Song, Yuan
|
|
2019
|
10 |
4 |
p. 1473-1485
|
artikel
|
| 48 |
Prevalence of Diabetes and Prediabetes in Adults from a Third-Tier City in Eastern China: A Cross-Sectional Study
|
Song, Yuan
|
|
|
10 |
4 |
p. 1473-1485
|
artikel
|
| 49 |
Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4 Inhibitor
|
Ishii, Hitoshi
|
|
2019
|
10 |
4 |
p. 1369-1380
|
artikel
|
| 50 |
Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4 Inhibitor
|
Ishii, Hitoshi
|
|
|
10 |
4 |
p. 1369-1380
|
artikel
|
| 51 |
Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes
|
Shigiyama, Fumika
|
|
2019
|
10 |
4 |
p. 1509-1521
|
artikel
|
| 52 |
Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes
|
Shigiyama, Fumika
|
|
|
10 |
4 |
p. 1509-1521
|
artikel
|
| 53 |
Response to ‘Comment on “Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report” by Hsieh et al.’
|
Hsieh, Hui-Chi
|
|
2019
|
10 |
4 |
p. 1551-1552
|
artikel
|
| 54 |
Response to ‘Comment on “Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report” by Hsieh et al.’
|
Hsieh, Hui-Chi
|
|
|
10 |
4 |
p. 1551-1552
|
artikel
|
| 55 |
Results of Insulin Therapy in Type 2 Diabetes Mellitus Patients in the Czech Republic: Do They Reflect the Current Status in Other Countries?
|
Brož, Jan
|
|
2019
|
10 |
4 |
p. 1181-1188
|
artikel
|
| 56 |
Results of Insulin Therapy in Type 2 Diabetes Mellitus Patients in the Czech Republic: Do They Reflect the Current Status in Other Countries?
|
Brož, Jan
|
|
|
10 |
4 |
p. 1181-1188
|
artikel
|
| 57 |
Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care Setting
|
Strain, W. David
|
|
2019
|
10 |
4 |
p. 1499-1507
|
artikel
|
| 58 |
Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care Setting
|
Strain, W. David
|
|
|
10 |
4 |
p. 1499-1507
|
artikel
|
| 59 |
Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy
|
Langer, Jakob
|
|
2019
|
10 |
4 |
p. 1347-1356
|
artikel
|
| 60 |
Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy
|
Langer, Jakob
|
|
|
10 |
4 |
p. 1347-1356
|
artikel
|
| 61 |
Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis
|
Lu, Hongtao
|
|
2019
|
10 |
4 |
p. 1487-1497
|
artikel
|
| 62 |
Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis
|
Lu, Hongtao
|
|
|
10 |
4 |
p. 1487-1497
|
artikel
|
| 63 |
The Potential Impact of the FreeStyle Libre Flash Glucose Monitoring System on Mental Well-Being and Treatment Satisfaction in Patients with Type 1 Diabetes: A Prospective Study
|
Al Hayek, Ayman A.
|
|
2019
|
10 |
4 |
p. 1239-1248
|
artikel
|
| 64 |
The Potential Impact of the FreeStyle Libre Flash Glucose Monitoring System on Mental Well-Being and Treatment Satisfaction in Patients with Type 1 Diabetes: A Prospective Study
|
Al Hayek, Ayman A.
|
|
|
10 |
4 |
p. 1239-1248
|
artikel
|
| 65 |
Using Clinical Indices to Distinguish MODY2 (GCK Mutation) and MODY3 (HNF1A Mutation) from Type 1 Diabetes in a Young Chinese Population
|
Fu, Junling
|
|
2019
|
10 |
4 |
p. 1381-1390
|
artikel
|
| 66 |
Using Clinical Indices to Distinguish MODY2 (GCK Mutation) and MODY3 (HNF1A Mutation) from Type 1 Diabetes in a Young Chinese Population
|
Fu, Junling
|
|
|
10 |
4 |
p. 1381-1390
|
artikel
|
Tijdschrift beschrijving